Resistance to activated protein C due to factor V Leiden mutation: High prevalence in patients with post-thrombotic leg ulcers

British Journal of Dermatology

Volumn 144, Issue 3, 2001, Pages 546-548

  Gaber, Y ^a   Siemens, H J ^a   Schmeller, W ^b  

^a UNIVERSITY OF LÜBECK   (Germany)

^b Rosenparkklinik GmbH   (Germany)

Author keywords

Activated protein C resistance; Factor V Leiden mutation; Post thrombotic syndrome; Prevalence; Primary varicosis; Venous leg ulcers

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 5 LEIDEN;

ACTIVATED PROTEIN C RESISTANCE; ARTICLE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; GENE MUTATION; HUMAN; LEG ULCER; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; POSTTHROMBOSIS SYNDROME; PREVALENCE; PRIORITY JOURNAL; VARICOSIS;

ACTIVATED PROTEIN C RESISTANCE; AGED; FACTOR V; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POINT MUTATION; POSTPHLEBITIC SYNDROME; RISK FACTORS; VARICOSE ULCER;

EID: 0035082284     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2001.04081.x     Document Type: Article

References (23)

1. Consensus paper on venous leg ulcers
2. Diagnosis of chronic venous disease of the lower extremities: The 'CEAP' classification
3. Epidemiology of chronic venous ulcers
4. Spätfolgen der tiefen venenthrombose: Ein 13-Jahres follow-up von 223 patienten
5. Inherited thrombophilia: Resistance to activated protein C as a pathogenetic factor of venous thromboembolism
6. Resistance to activated protein C and factor V Leiden as risk factors for venous thrombosis
7. Activated protein C resistance: Molecular mechanisms
8. Pulmonary embolism and deep venous thrombosis during pregnancy or oral contraceptive use: Prevalence of factor V Leiden
9. Venous thrombosis due to poor anticoagulant response to activated protein C. Leiden thrombophilia study
10. APC-resistance is a risk factor for postoperative thromboembolism in elective replacement of the hip or knee - A prospective study
11. Oral contraceptives enhance the risk of clinical manifestation of venous thrombosis at a young age in females homozygous for factor V Leiden
12. Resistance to activated protein C as a basis for venous thrombosis
13. Evaluation of original and modified APC-resistance tests in unselected outpatients with clinically suspected thrombosis and in healthy controls
14. Mutation in blood coagulation factor V associated with resistance to activated protein C
15. 506→Gln mutation in the gene for factor V (factor V Leiden)
16. Thromboserisiko bei oralen kontrazeptiva: Stellenwert eines thrombophilie-screenings
17. Factor V Leiden mutation and contraception
18. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation
19. Superficial vein thrombosis of lower limbs: Influence of factor V Leiden, factor II G20210A and overweight
20. The risk of recurrent thromboembolism in patients with and without factor V Leiden
21. Resistance to activated protein C: A common deficiency in patients with venous leg ulceration
22. Activated protein C resistance and anticardiolipin antibodies in patients with venous leg ulcers
23. The prevalence of factor V Leiden mutation in patients with leg ulcers and chronic venous insufficiency